Big Picture Bio develops predictive models to identify synergistic drug combinations, with a focus on cancer therapies designed to prevent or overcome treatment resistance.
Big Picture Bio has raised €2.6M across 1 funding round from 5 investors, most recently a Pre-Seed round in Sep 2026. Based in London, UK; active in Healthtech. Data as of 18 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-18 | Pre-Seed |
| €2.6M |
| Exceptional Ventures,Gloucester Ventures,Innovate UK’s Investor Partnerships Programme,John White,Kadmos Capital |
| View deal → |
